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Adultswhowere born pretermwith avery lowbirthweight havehigher bloodpressure and impaired glucose regulation
later in life compared with those born at term. We investigated cardiometabolic risk factors in young adults who were
born at any degree of prematurity in thePretermBirth andEarly LifeProgramming of Adult Health andDisease (ESTER)
Study, a population-based cohort study of individuals born in 1985–1989 in Northern Finland. In 2009–2011, 3 groups
underwent clinical examination: 134 participants born at less than 34 gestational weeks (early preterm), 242 born at 34–
36 weeks (late preterm), and 344 born at 37 weeks or later (controls). Compared with controls, adults who were born
preterm had higher body fat percentages (after adjustment for sex, age, and cohort (1985–1986 or 1987–1989), for
those born early preterm, difference = 6.2%, 95% confidence interval (CI): 0.4, 13.2; for those born late preterm,
difference = 8.0%, 95% CI: 2.4, 13.8), waist circumferences, blood pressure (for those born early preterm, difference =
3.0 mmHg, 95%CI: 0.9, 5.1; for those born late preterm, difference = 1.7, 95%CI:−0.1, 3.4), plasmauric acid levels (for
those born early preterm, difference = 20.1%, 95% CI: 7.9, 32.3; for those born late preterm, difference = 20.2%, 95%
CI: 10.7, 30.5), alanine aminotransferase levels, and aspartate transaminase levels. They were also more likely to have
metabolic syndrome (for those born early preterm, odds ratio = 3.7, 95% CI: 1.6, 8.2; for those born late preterm, odds
ratio = 2.5, 95% CI: 1.2, 5.3). Elevated levels of conventional and emerging risk factors suggest a higher risk of cardio-
metabolic disease later in life. These risk factors are also present in the large group of adults born late preterm.
blood pressure; glucose metabolism; hypertension; late preterm; obesity; prematurity
Abbreviations: BMI, body mass index; CI, confidence interval; FMBR, Finnish Medical Birth Register; HDL-C, high-density
lipoprotein cholesterol; NFBC, Northern Finland Birth Cohort 1986.
Each year, 14.9 million infants worldwide, approximately
1 of every 9 who are liveborn, are born before 37 weeks of
gestation (1–3). There is increasing evidence that the smallest
and most immature of them, such as those born with very low
birth weight (<1,500 g) or born very preterm (<32 weeks),
have higher levels of cardiometabolic risk factors as adults,
including elevated blood pressure (4–9), impaired glucose
regulation (10, 11), and atherogenic lipid proﬁles (9). How-
ever, most of this evidence is limited to these conventional
cardiometabolic risk factors in the extreme groups of adults
born at very low birth weight or very preterm.
Of all preterm infants in the United States, 70% are born
late preterm, that is, between 34 and 36 weeks of gestation
(12); in the European Union, more than 80% of preterm
infants are born moderately preterm, that is, between 32 and
36 weeks of gestation (2). Yet, only few studies investigating
adult cardiometabolic risks have included the whole range of
preterm births. Results from these studies have suggested that
a linear relationship exists between a shorter gestation period
and higher blood pressure in adult life (13, 14). Should a sim-
ilar “dose-response” relationship exist for other cardio-
metabolic risk factors, even moderately higher risks in the
much larger group of people born late or moderately preterm
could potentially cause a larger public health burden.
We hypothesized that preterm birth at all levels is associ-
ated with cardiometabolic risk factors in adult life. We tested
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this hypothesis in a cohort of young adults by using both con-
ventional risk factors, such as body size and the established
components and criteria of the metabolic syndrome, and
emerging risk factors that may reﬂect speciﬁc pathophysio-
logical pathways, such as body composition, plasma apolipo-
proteins, uric acid, and markers of inﬂammation and fatty
liver disease.
METHODS
The present study is part of the Preterm Birth and Early
Life Programming of Adult Health and Disease (ESTER)
Study, the design ofwhich is depicted inFigure 1.Theoriginal
cohort comprised 1980 individuals born in Northern Finland,
987 (49.8%) of whom came from the Northern Finland Birth
Cohort 1986 (NFBC; born in 1985–1986) (13); the remain-
ing 993 (50.2%) were recruited from all individuals born in
the same geographical area in 1987–1989 and were identiﬁed
through the Finnish Medical Birth Register (FMBR). The
numbers of thosewhowere invited and those who participated
are shown in Figure 1. From the NFBC, we invited all individ-
uals who were born either early preterm (born before 34 ges-
tational weeks) or late preterm (born at 34–36 gestational
weeks); from the FMBR, we recruited all individuals who
were born early preterm. Furthermore, to attain approximately
double the total number of participants in the late preterm
Recruited Through Northern Finland Birth Cohort 1986
(NFBC, 1985–1986; n = 987)
102 at <34 weeks of gestation
306 at 34–36 weeks of gestation
579 at ≥37 weeks of gestation
Recruited Through Finnish Medical Birth Register
(FMBR, 1987–1989; n = 993)
217 at <34 weeks of gestation
335 at 34–36 weeks of gestation
441 at ≥37 weeks of gestation 
Nonparticipants (n = 608)
53 at <34 weeks of gestation
192 at 34–36 weeks of gestation
363 at ≥37 weeks of gestation
Nonparticipants (n = 593)
114 at <34 weeks of gestation
183 at 34–36 weeks of gestation
296 at ≥37 weeks of gestation
Participated in the ESTER Study (n = 779)
152 at <34 weeks of gestation
266 at 34–36 weeks of gestation
361 at ≥37 weeks of gestation
Length of Gestation Confirmed From
Medical Records
149 Early preterm
248 Late preterm
380 Controls 
Excluded From Analysis (n = 59)
2 Participants with missing
gestational age
27 Participants  invited as
preterm, but found out to be
full term
15 Participants with severe
disability 
18 Participants who were
pregnant 
Included in the Analysis (n = 720)
134 Early preterm
242 Late preterm
344 Controls
Figure 1. Flow chart of the study population, Northern Finland, 2009–2011. All subjects who were recruited into the study were born in Northern
Finland in 1986–1989. In the FinnishMedical Birth Register data, therewere 83 individuals in the random control group who hadmissing gestational
age, 58 of whom did not participate in the Preterm Birth and Early Life Programming of Adult Health and Disease (ESTER) Study and 25 of whom
participated. Ten subjects who were born early preterm, 1 subject who was born late preterm, and 4 controls reported severe disability and were
excluded from the analysis. Five subjects who were born early preterm, 5 subjects who were born late preterm, and 8 controls reported being preg-
nant and were excluded from the analysis. Three of the excluded subjects had more than 1 reason for exclusion.
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group as in the early preterm group, we recruited a randomly
selected sample of individuals born late preterm from the
FMBR. From both cohorts, we recruited a group of randomly
selected controls (Figure 1). Because of slight variation in
number of individuals recruited through the cohorts, we ad-
justed for recruitment cohort (NFBC or FMBR) in all the
analyses.
In 2009–2011, a total of 779 individuals participated in a
clinical study.After veriﬁcation of the length of gestation from
medical records (15),we excluded2participantswhose length
of gestation could not be veriﬁed and 27 subjects thought to
be born preterm whowere actually born at term (Web Table 1
available at http://aje.oxfordjournals.org/). Those who were
pregnant (n = 18) or who reported having cerebral palsy (n =
6), a mental disability (n = 7), and/or another severe physical
disability (n = 3) were excluded from analysis because these
conditions might affect the main outcomes. Three subjects
had more than 1 criterion for exclusion. In addition, 7 sub-
jects reported the use of β-blockers for indications other than
hypertension, and they were excluded from the blood pres-
sure analysis. Thus, there were 134 participants who were
born early preterm, 242 participants who were born late pre-
term (16), and 344 controls who were born at term. The peri-
natal data are shown in Table 1.
We compared persons who participated with those who
did not or who were excluded from the analysis because
of pregnancy or physical disability. This comparison was
based on perinatal data from the NFBC database (partic-
ipants from NFBC) and the FMBR (participants born be-
tween 1987 and 1989). In addition, we compared the results
of the clinical examinations that took place at 16 years of
age among those NFBC members who had participated in
that examination. The comparative data are shown in Web
Table 2.
Perinatal data
The perinatal data from the participants recruited through
the NFBC (born in 1985–1986) came from the cohort data-
base; the information was originally collected from medical
records (13). We collected corresponding data from those
invited through the FMBR (born in 1987–1989) from their
hospital and maternal welfare clinic records. We retrospec-
tively conﬁrmed the length of gestation (determined by ul-
trasonography in 62.7% of preterm infants and 53.1% of
controls) (15) and diagnoses of maternal gestational diabe-
tes, hypertension (gestational or chronic), or preeclampsia
(including superimposed) according to prevailing criteria
by reviewing original hospital records (17, 18). We calcu-
lated birth weight standard deviation scores according to
Finnish birth weight standards, which are based on 75,061
singletons born in 1979–1983 in Finland (19). Although these
standards are based on newborn measurements, they assume
a constant coefﬁcient of variation (standard deviation/mean
ratio) at each gestational week, analogous to fetal growth
standards based on ultrasound measurements (20, 21). We
deﬁned “small for gestational age” as less than 2 standard de-
viations below and “large for gestational age” as more than
2 standard deviations above the mean for sex and length of
gestation.
Clinical examination
The subjects attended the clinic at 7:30–9:00 AM after an
overnight fast and were examined by 2 trained study nurses.
After a 5-minute rest in a sitting position, participants had
their blood pressure measured 3 times from the right upper
arm using an automatic oscillometric blood pressure monitor
(Omron M10-IT Intellisense, Omron Healthcare Co., Kyoto,
Japan). Subjects with a systolic blood pressure of 140 mm
Hg or higher or a diastolic blood pressure of 90 mm Hg or
higher were classiﬁed as having hypertension (22). Height
was measured 3 times. The waist circumference, which was
measured midway between the lowest rib and the iliac crest,
and the hip circumference, which was measured at the widest
point of the hip, were both measured twice. The mean values
of these measurements, the waist-hip ratio, and body mass
index (BMI; weight in kilograms divided by height in meters
squared) were calculated. Subjects with a BMI higher than 30
were classiﬁed as obese. We used a segmental multifrequency
bioelectrical impedance (InBody 3.0, Biospace Co., Seoul,
Korea) to assess body composition (weight, lean body mass,
fat mass, and percentage of body fat). Blood samples were col-
lected after fasting and 2 hours after a 75-gram oral glucose
load. The laboratory analyses are described in theWeb Appen-
dix. To test for metabolic syndrome, we used the criteria from
the joint interim statement by Alberti et al. (23). Three or more
of the following 5 criteria had to be met: 1) central obesity
(waist circumference ≥94 cm in men and ≥80 cm in women);
2) triglycerides ≥1.7 mmol/L; 3) high density lipoprotein cho-
lesterol (HDL-C) level <1.03 mmol/L in men and <1.29 mmol
in women; 4) blood pressure ≥130/85 mm Hg; and 5) fasting
plasma glucose level ≥5.6 mmol/L or type 2 diabetes melli-
tus. We calculated the fatty liver index as (e0.953 × ln (triglycerides,
mg/dL) + 0.139 ×BMI + 0.718 × ln (γ glutamate, U/L) + 0.053 ×waist circumference
− 15.745)/(1 + e0.953 × ln (triglycerides, mg/dL) + 0.139 × BMI + 0.718 × ln (γ
glutamate, U/L) + 0.053 × waist circumference− 15.745) × 100 (conversion
for triglycerides: 1 mg/dL = 18.0182 × 1 mmol/L) (24). The par-
ticipants completed questionnaires that included questions about
their medical histories, medication use, socioeconomic status,
and lifestyles. Socioeconomic status was assessed using the
highest educational level of each subject’s more highly educated
parent and was categorized in 4 levels (dummy coded). Self-
reported physical activity levels were converted to total meta-
bolic equivalent hours per week (25). The research protocol
was approved by the Coordinating Ethics Committee at Helsinki
and Uusimaa Hospital District, and all the participants provided
written informed consent.
Statistical methods
All statistical analyses were performed using SPSS for
Windows, version 21 (SPSS Inc., Chicago, Illinois). The
main outcome variables according to pathophysiological
pathways are presented in the Web Table 3. To account for
non-normal distribution of residuals or heteroscedasticity of
the dependent variable, we log-transformed all continuous
variables except blood pressure, height, and concentrations
of uric acid, albumin, and urea. We compared the character-
istics of the subjects in the early preterm and late preterm
groups with those of the controls using Student’s t test and
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Table 1. Perinatal, Neonatal, and Current Characteristics of Cases and Controls, Northern Finland, 2009–2011
Characteristic
Early Preterm (n = 134)
P
Valuea
Late Preterm (n = 242)
P
Valuea
Controls (n = 344)
No. % Mean (SD) No.Missing No. % Mean (SD)
No.
Missing No. % Mean (SD)
No.
Missing
Male 65 48.5 0.95 120 49.6 0.86 168 48.8
Peri- and neonatal characteristics
Pregnancy with multiple fetuses 32 23.9 <0.001 34 14.0 <0.001 4 1.2
Maternal hypertensionb 17 12.7 0 0.51 36 15.2 5 0.10 36 10.6 4
Maternal preeclampsiac 32 23.9 0 <0.001 22 9.3 5 <0.001 16 4.7 4
Maternal gestational diabetes 4 3.5 21 0.28 11 5.0 24 0.03 6 1.8 9d
Maternal smoking during pregnancy 21 16.5 7 0.94 46 19.3 4 0.44 57 16.8 5
Cesarean delivery 80 59.7 <0.001 67 27.7 <0.001 41 11.9
Gestational age, weeks 31.8 (2.0) <0.001 35.8 (0.8) <0.001 40.1 (1.2)
Birth weight, grams 1,786 (493) <0.001 2,674 (515) <0.001 3,576 (483)
Birth weight SD score −0.73 (1.4) <0.001 −0.63 (1.3) <0.001 −0.02 (1.0)
Small for gestational age 22 16.4 <0.001 30 12.4 <0.001 7 2.0
Large for gestational age 4 3.0 0.91 5 2.1 0.41 11 3.2
Respirator treatment 68 50.7 <0.001 28 11.6 <0.001 2 0.6
Duration of respirator treatment, dayse 7.0 (10.4) 0.55 2.8 (2.7) 0.86 2.5 (0.7)
Supplementary oxygen 98 73.1 <0.001 93 38.4 <0.001 7 2.0
Duration of supplementary oxygen, daysf 9.0 (14.1) 0.15 2.0 (3.6) 0.59 1.3 (1.9)
Current
Age, years 23.1 (1.4) <0.001 23.2 (1.3) <0.001 23.6 (1.1)
Parental educational level 1 0.51 5 0.62 4
Basic or less or unknown 12 9.0 19 8.0 20 5.9
Secondary 81 60.9 134 56.5 207 60.9
Lower-level tertiary 13 9.8 31 13.1 45 13.2
Upper-level tertiary 27 20.3 53 22.4 68 20.0
Maternal history of hypertension 19 15.1 8 0.53 39 16.9 3 0.18 42 12.8 17
Maternal history of diabetes 3 2.4 8 0.41 17 7.4 12 0.08 13 4.0 16
Maternal history of myocardial
infarction or stroke
2 1.6 7 0.13 4 1.7 12 0.08 1 0.3 17
Paternal history of hypertension 19 15.2 9 0.62 39 17.3 16 0.97 56 17.1 17
Paternal history of diabetes 6 4.8 9 0.07 20 8.8 16 0.63 33 10.1 17
Paternal history of myocardial
infarction or stroke
8 6.4 9 0.81 15 6.6 15 0.69 19 5.8 17
Self-reported physical activity,
MET-hours/week
23.5 (13.8) 4 0.08 24.9 (14.5) 7 0.35 26.0 (13.8) 10
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the χ2 test and compared the main outcomes using linear or
logistic regression. We ﬁrst estimated the crude effect of pre-
term birth in model 1, which included age, cohort (NFBC or
FMBR), and sex. In model 2, to assess the total effect, we ad-
justed for variables in model 1 in addition to parental and pre-
natal confounding factors (including parental educational
level as a proxy of childhood socioeconomic position, mater-
nal smoking during pregnancy, and birth weight standard
deviation scores as indicators of fetal conditions during preg-
nancy) and, for analyses of dichotomous and biochemical
outcomes, parental history of hypertension, diabetes, and
myocardial infarction or stroke as proxies for genetic suscep-
tibility. We report additional adjustments for maternal hyper-
tension in pregnancy and gestational diabetes in the Results.
In model 3, we adjusted for the variables in model 1 and for
the current characteristics at the time of study: height (for
body composition and blood pressure) or BMI (for blood
pressure and biochemical risk factors), physical activity level,
and smoking status. For fatty liver index, we also adjusted for
current alcohol use. Model 4 included both the confounders
and intermediate factors to assess the direct association of pre-
term birth with these outcomes. The associations between pre-
term birth and the outcomes were similar in men and women,
except for HDL-C and apolipoprotein A1, for which the P val-
ues for interaction terms between sex and early preterm birth
were 0.035 and 0.019 (adjusted for age and sex), respectively.
For this reason, we report comparisons of plasma lipid levels
separately for women and men. All P values are 2-sided.
RESULTS
Obesity and body composition
The characteristics of the study groups are presented in
Table 1. Subjects whowere born preterm were approximately
2 times more likely to be obese than were controls (Figure 2
and Table 2), which was reﬂected in their higher mean body
mass indices and waist circumferences (Table 3). Waist cir-
cumferences, waist-hip ratios, and (with borderline signiﬁ-
cance for the early preterm group) percentages of body fat
were higher in both early and late preterm groups than in the
controls; lean body masses were similar (Table 3).
Blood pressure
Hypertension was 2 to 3 times more common in adults
who were born preterm (Figure 2 and Table 2), although
this was not statistically signiﬁcant for the late preterm group.
Adults who were born early preterm had systolic blood pres-
sures that were 3.0 mm Hg higher and diastolic blood pres-
sures that were 2.6 mm Hg higher than did the controls
(Table 4). The difference remained statistically signiﬁcant
after adjustment for covariates.
Glucose metabolism
One subject who was born late preterm reported using med-
ication for type 2 diabetes mellitus and was excluded from the
analyses of glucose metabolism. Subjects who were born late
preterm had higher fasting and 2-hour insulin concentrationsTa
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Figure 2. Prevalence of hypertension, obesity, metabolic syndrome, and fatty liver index greater than 30 in adults who were born early preterm or
late preterm compared with adults born at term (controls), Northern Finland, 2009–2011.
Table 2. Odds Ratios for Hypertension, Obesity, Fatty Liver Index, and Metabolic Syndrome in Adults Who Were
Born Preterm Compared With Controls Who Were Born at Full Term, Northern Finland, 2009–2011
Outcome Variable and
Modela
Early Preterm Late Preterm
Total No.
OR 95% CI P Value OR 95% CI P Value
Obesity
1 2.2 1.1, 4.1 0.02 1.7 1.0, 3.1 0.06 720
2 2.5 1.2, 4.8 0.009 1.8 1.0, 3.3 0.06 704
3 2.0 1.0, 4.0 0.04 1.8 1.0, 3.3 0.05 699
4 2.4 1.2, 4.9 0.01 1.9 1.0, 3.5 0.05 683
Hypertension
1 2.7 1.3, 5.3 0.005 1.7 0.9, 3.2 0.10 711
2 3.0 1.4, 6.2 0.004 1.6 0.8, 3.2 0.16 695
3 2.6 1.3, 5.4 0.01 1.6 0.8, 3.1 0.15 690
4 2.4 1.1, 5.3 0.03 1.4 0.7, 2.9 0.37 674
Metabolic syndrome
1 3.7 1.6, 8.2 0.002 2.5 1.2, 5.3 0.02 711
2 4.3 1.9, 10.1 <0.001 2.4 1.1, 5.4 0.03 696
3 3.6 1.6, 8.3 0.003 2.7 1.2, 5.8 0.01 692
4 4.6 1.9, 11.1 <0.001 2.7 1.2, 6.0 0.02 677
Fatty liver index >30
1 13.6 1.5, 120.0 0.02 8.6 1.0, 72.8 0.05 706
2 11.6 1.3, 106.1 0.03 7.5 0.8, 65.4 0.07 691
3 12.5 1.4, 111.2 0.02 8.5 1.0, 72.0 0.05 681
4 10.8 1.2, 100.2 0.04 7.0 0.8, 61.4 0.08 666
a Model 1 was adjusted for sex, age, and cohort. Model 2 was adjusted for the variables in model 1 and parental
educational level, maternal smoking during pregnancy, birth weight standard deviation score, and parental
hypertension, diabetes, and myocardial infarction/stroke. Model 3 was adjusted for the variables in model 1 and
self-reported physical activity level and daily smoking (and fatty liver index for alcohol user). Model 4 was adjusted for
the variables in models 2 and 3.
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and higher indices of homeostatic model assessment for insu-
lin resistance than did the controls (Table 4). These differences
were minimally changed after adjustment for parental and
prenatal confounders but became attenuated after adjustment
for current characteristics. Glucose concentrations were similar
in all the groups. Eight (3.3%) of the late preterm subjects and
Table 3. Geometric Mean Valuesa of Body Size and Composition Variables in Controls and Mean Differences Between Young Adults WhoWere
Born Preterm and Controls, Northern Finland, 2009–2011
Measure and
Modelb
Controls, mean (SD) Early Preterm Late Preterm
Total
No.Women Men MeanDifference, % 95% CI
P
Valuec
Mean
Difference, % 95% CI
P
Valuec
Height,d cm 164.0 (6.0) 177.6 (7.0)
1 0.4 −0.9, 1.6 0.59 0.5 −0.6, 1.5 0.38 720
2 1.7 0.5, 3.0 0.006 1.7 0.7, 2.7 0.001 704
3 0.3 −1.0, 1.6 0.64 0.4 −0.7, 1.4 0.49 699
4 2.0 0.8, 3.2 0.001 1.8 0.8, 2.8 <0.001 683
Body mass index 22.0 (0.19) 23.0 (0.19)
1 1.8 −1.8, 5.3 0.29 2.9 0.1, 5.8 0.03 720
2 2.6 −0.9, 6.3 0.15 3.7 0.8, 6.7 0.007 704
3 1.9 −1.5, 5.5 0.27 3.1 0.2, 6.0 0.04 699
4 3.4 −0.6, 6.8 0.98 4.1 1.1, 7.1 0.004 683
Waist circumference, cm 73.7 (0.13) 82.3 (0.10)
1 3.6 1.2, 6.1 0.002 3.3 1.3, 5.3 0.001 719
2 4.4 1.9, 7.0 <0.001 3.9 1.9, 6.0 <0.001 703
3 3.5 1.0, 6.0 0.007 3.2 1.2, 5.3 0.002 698
4 4.0 1.4, 6.6 0.002 3.6 1.8, 5.7 <0.001 682
Waist-hip ratio 0.81 (0.05) 0.90 (0.05)
1 1.8 0.7, 2.9 <0.001 1.3 0.4, 2.1 0.003 719
2 1.8 0.8, 3.0 <0.001 1.3 0.5, 2.2 0.003 703
3 1.6 0.5, 2.7 0.003 1.3 0.4, 2.1 0.004 698
4 1.7 0.6, 2.9 0.03 1.4 0.5, 2.3 0.002 682
Lean body mass, kg 43.2 (0.13) 61.5 (0.15)
1 −0.2 −2.8, 2.5 0.88 1.3 −0.9, 3.5 0.30 718
2 2.5 −0.2, 5.2 0.07 3.6 1.4, 5.8 0.001 702
3 −0.5 −2.5, 1.5 0.61 0.8 −0.8, 2.5 0.32 697
4 0.4 −1.6, 2.6 0.68 1.6 −0.1, 3.3 0.07 681
Fat mass, kg 15.7 (0.52) 11.5 (0.57)
1 8.5 −0.1, 18.9 0.08 11.7 3.7, 20.4 0.004 718
2 10.1 0.1, 21.1 0.05 13.5 5.1, 22.6 0.001 702
3 9.1 −0.5, 19.7 0.06 11.8 3.7, 20.6 0.004 697
4 11.4 1.1, 22.7 0.03 14.1 5.5, 23.4 <0.001 681
Percentage body fat, % 26.0 (0.32) 15.4 (0.42)
1 6.2 −0.4, 13.2 0.07 8.0 2.4, 13.8 0.004 718
2 5.2 −1.6, 12.5 0.14 7.4 1.7, 13.4 0.01 702
3 7.0 0.6, 14.0 0.03 8.5 3.1, 14.2 0.002 697
4 8.1 1.2, 15.5 0.02 9.7 4.0, 15.7 <0.001 681
Abbreviations: CI, confidence interval; SD, standard deviation.
a The geometricmean is the nth root of the product of n values. The geometric SD corresponds to the percentage of the increase in a variable that
corresponds to a 1-SD change in the logarithm of the variable.
b Model 1 was adjusted for sex, age, and cohort. Model 2 was adjusted for the variables in model 1 and parental educational level, maternal
smoking during pregnancy, and birth weight SD score. Model 3 was adjusted for the variables in model 1 and height (except for height),
self-reported physical activity level, and daily smoking. Model 4 was adjusted for the variables in models 2 and 3.
c P values are for the differences between means in the preterm groups and controls.
d Values are expressed as arithmetic mean (SD) in centimeters.
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Table 4. Geometric Mean Valuesa of Blood Pressure and Biochemical Measurements in Controls and Mean Differences Between Adults Who
Were Born Preterm and Controls, Northern Finland, 2009–2011
Measure and Modelb
Controls,
mean (SD)
Early Preterm Late Preterm
Total
No.Mean
Difference
95% CI
P
Valuec
Mean
Difference
95% CI
P
Valuec
Systolic blood pressure,d mm Hg 116.3 (12.3)
1 3.0 0.9, 5.1 0.005 1.7 −0.1, 3.4 0.06 711
2 3.2 1.1, 5.4 0.003 1.5 −0.3, 3.3 0.10 695
3 2.7 0.7, 4.8 0.01 1.4 −0.3, 3.1 0.11 699
4 2.1 −0.0, 4. 0.05 0.8 −1.0, 2.5 0.42 674
Diastolic blood pressure,d mm Hg 75.4 (7.6)
1 2.6 0.9, 4.2 0.002 1.2 −0.1, 2.5 0.07 711
2 2.3 0.7, 4.0 0.006 0.8 −0.5, 2.1 0.24 695
3 2.4 0.9, 4.0 0.002 1.0 −0.2, 2.3 0.11 699
4 1.7 0.1, 3.3 0.04 0.4 −0.9, 1.7 0.56 674
Fasting plasma glucose level, mmol/L 5.1 (1.09)
1 0.8 −0.8, 2.4 0.35 0.3 −1.0, 1.6 0.68 710
2 0.8 −0.9, 2.4 0.36 0.0 −1.3, 1.4 0.99 695
3 0.5 −1.1, 2.1 0.53 0.1 −1.2, 1.4 0.84 691
4 0.3 −1.3, 2.0 0.71 −0.3 −1.6, 1.1 0.71 676
2-Hour plasma glucose level, mmol/L 6.6 (1.17)
1 −0.4 −3.9, 3.2 0.83 1.1 −1.8, 4.0 0.46 695
2 −1.6 −5.2, 2.1 0.40 −0.5 −3.4, 2.5 0.65 680
3 −0.8 −4.1, 2.7 0.66 1.1 −1.7, 4.0 0.44 680
4 −2.1 −5.5, 1.5 0.26 −0.4 −3.3, 2.5 0.91 665
Fasting serum insulin
concentration, pmol/L
46.2 (1.51)
1 8.8 −1.0, 19.6 0.08 10.1 1.9, 19.0 0.02 689
2 7.3 −2.8, 18.4 0.16 7.5 −0.7, 16.5 0.07 674
3 4.0 −4.1, 12.8 0.34 4.8 −4.1, 12.8 0.17 670
4 1.1 −7.1, 10.0 0.80 1.7 −5.0, 8.8 0.64 655
2-Hour serum insulin concentration,
pmol/L
150.9 (2.04)
1 15.5 −0.1, 33.6 0.05 16.5 3.0, 31.7 0.02 656
2 10.4 −4.3, 27.3 0.17 11.7 −0.7, 25.9 0.07 656
3 8.5 −5.8, 25.1 0.26 12.6 0.3, 26.3 0.04 641
4 2.7 −11.2, 18.8 0.71 4.0 −7.5, 16.9 0.51 626
Homeostatic model assessment for
insulin resistance
0.90 (1.50)
1 8.9 −0.9, 19.7 0.08 9.8 1.6, 18.6 0.02 688
2 7.5 −2.6, 18.6 0.15 7.2 −1.0, 16.1 0.09 673
3 4.1 −4.0, 12.9 0.33 4.7 −2.0, 12.9 0.33 669
4 1.2 −7.0, 10.1 0.78 1.5 −5.2, 8.7 0.66 654
Fasting plasma uric acid level,d
µmol/L
292.1 (68.8)
1 20.1 7.9, 32.3 0.001 20.1 10.7, 30.5 <0.001 708
2 19.2 6.4, 31.9 0.003 18.6 8.3, 28.9 <0.001 693
3 20.3 8.7, 32.0 <0.001 18.4 8.9, 27.8 <0.001 689
4 18.8 6.7, 30.9 0.002 16.1 6.3, 25.8 0.001 674
Table continues
868 Sipola-Leppänen et al.
Am J Epidemiol. 2015;181(11):861–873
Table 4. Continued
Measure and Modelb
Controls,
mean (SD)
Early Preterm Late Preterm
Total
No.Mean
Difference
95% CI
P
Valuec
Mean
Difference
95% CI
P
Valuec
High-sensitivity C-reactive protein
level, mg/L
1.0 (3.23)
1 −3.4 −24.6, 23.7 0.78 −9.4 −25.9, 10.7 0.34 649
2 −5.9 −27.5, 22.2 0.65 −12.2 −28.8, 8.3 0.22 634
3 −11.1 −30.2, 13.2 0.34 −14.0 −29.3, 4.6 0.13 632
4 −17.5 −36.1, 6.4 0.14 −18.8 −33.7, −0.4 0.05 617
Blood leukocyte concentration, 109/L 5.8 (1.29)
1 5.5 0.0, 11.2 0.05 3.1 −1.2, 7.7 0.16 705
2 4.6 −1.0, 10.5 0.11 2.8 −1.7, 7.5 0.23 690
3 2.9 −2.2, 8.3 0.27 2.0 −2.1, 6.4 0.34 686
4 1.8 −3.5, 7.4 0.50 1.7 −2.6, 6.1 0.45 671
Plasma alanine aminotransferase
level, U/L
24.8 (1.67)
1 9.3 −0.6, 20.1 0.07 15.0 6.4, 24.2 <0.001 710
2 8.2 −2.0, 19.5 0.12 13.5 4.7, 22.9 0.002 695
3 8.4 −1.1, 18.95 0.08 13.3 5.1, 22.1 0.001 685
4 7.6 −2.3, 18.4 0.14 12.1 3.7, 21.1 0.004 670
Plasma aspartate transaminase
level, U/L
22.7 (1.41)
1 5.6 −1.5, 13.2 0.12 11.7 5.5, 18.2 <0.001 708
2 3.7 −3.6, 11.5 0.33 9.9 3.7, 16.6 0.002 693
3 7.4 0.1, 15.1 0.05 12.9 6.6, 19.5 <0.001 683
4 5.5 −1.9, 13.5 0.15 11.2 4.8, 17.9 <0.001 668
Plasma albumin level,d g/L 46.7 (2.6)
1 0.6 0.08, 1.0 0.02 −0.1 −0.5, 0.3 0.20 710
2 0.4 −0.05, 0.9 0.08 −0.07 −0.5, 0.3 0.36 695
3 0.6 0.1, 1.1 0.01 −0.1 −0.5, 0.3 0.52 691
4 0.5 0.0, 1.0 0.04 −0.1 −0.5, 0.3 0.79 676
Plasma γ glutamate level,d U/L 18.9 (1.77)
1 3.5 −6.7, 14.8 0.51 5.7 −2.8, 15.0 0.18 710
2 2.1 −8.4, 13.8 0.71 4.1 −4.6, 13.7 0.53 695
3 1.7 −7.9, 12.2 0.74 4.1 −4.0, 12.8 0.33 676
4 −0.4 −10.1, 10.4 0.94 2.4 −5.8, 11.3 0.58 670
Plasma urea level,d mmol/L 5.3 (2.5)
1 0.3 0.0, 0.5 0.04 −0.01 −0.2, 0.2 0.95 708
2 0.2 −0.1, 0.5 0.13 −0.03 −0.3, 0.2 0.77 693
3 0.3 0.0, 0.6 0.04 0.01 −0.2, 0.2 0.99 689
4 0.2 −0.0, 0.5 0.10 −0.02 −0.3, 0.2 0.83 674
a The geometricmean is the nth root of the product of n values. The geometric SD corresponds to the percentage of the increase in a variable that
corresponds to a 1-SD change in the logarithm of the variable.
b Model 1 was adjusted for sex, age, and cohort. Model 2 was adjusted for the variables in model 1 and parental educational level, maternal
smoking during pregnancy, birth weight SD score, and parental hypertension, diabetes, and myocardial infarction or stroke. Model 3 was
adjusted for the variables in model 1 and body mass index, self-reported physical activity level, and daily smoking, as well as plasma alanine
aminotransferase, aspartate transaminase, and γ glutamate for analyses of alcohol users and height for analyses of mean differences in systolic
and diastolic blood pressures. Model 4 was adjusted for the variables in models 2 and 3.
c P values are for the differences between means in the preterm groups and controls.
d Values are expressed as arithmetic mean (SD).
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11 (3.2%) of the controls had impaired glucose tolerance, and
1 (0.4%) subject who was born late preterm was found to have
diabetes after taking an oral glucose tolerance test.
Lipid profile
Women whowere born early preterm had 11.4% (95% con-
ﬁdence interval (CI): 5.6, 16.9) lower HDL-C and 9.7% (95%
CI: 4.5, 14.7) lower apolipoprotein A1 concentrations than did
women in the control group (Web Table 4). The differences
remained similar after we controlled for covariates. These as-
sociations were not present among men (Web Table 4). There
were no differences in triglyceride or total or low-density lipo-
protein cholesterol levels. No subjects used lipid-lowering
medications.
Metabolic syndrome
Of the 711 subjects who had adequate data, 46 (6.5%) ful-
ﬁlled the criteria of metabolic syndrome. Of the controls, 12
(3.5%) had the syndrome. Among those who were born early
preterm, 15 (11.5%) had the syndrome (after adjustment for
sex, age, and cohort, odds ratio = 3.7, 95% CI: 1.6, 8.2) (Fig-
ure 2 and Table 2). Among those who were born late preterm,
19 (17.9%) had the syndrome (odds ratio = 2.5, 95% CI: 1.2,
5.3) (Figure 2 and Table 2). The results were similar when
further adjustments were made for covariates (Table 2).
Other biochemical markers of metabolic syndrome
Subjects who were born preterm were 8 to 13 times more
likely to have an intermediate or high fatty liver index (24),
which is a proxy of nonalcoholic fatty liver disease (Figure 2,
Table 2). Of the individual markers of fatty liver disease,
alanine aminotransferase and aspartate transaminase con-
centrations were higher in those who were born preterm, al-
though this was statistically signiﬁcant for the late preterm
group only (Table 4). Concentrations of plasma uric acid, an-
other marker of metabolic syndrome, were 20.1% higher in
the subjects born early and late preterm (Table 4). In addition,
plasma albumin and plasma urea concentrations were higher
in those born early preterm than in the controls. As for mark-
ers of inﬂammation, the levels of blood leucocytes were
higher in those born early preterm (Table 4).
Associations of perinatal factors
To study whether perinatal conditions that might accom-
pany preterm birth contributed to our ﬁndings, we reanalyzed
the data by 1) excluding those who were born small for ges-
tational age, 2) excluding those who were born in connection
with a pregnancy of multiples, and 3) further adjusting the
analyses for maternal gestational diabetes. This did not alter
any of the conclusions of the study. We further adjusted the
analyses for maternal hypertension in pregnancy. When we
adjusted for the variables in model 4, we found that compared
with subjects whowere not exposed, those whowere exposed
to maternal hypertension had systolic blood pressures that
were 2.6 mmHg higher and diastolic blood pressures that were
2.0 mmHg higher. After adjustment formaternal hypertension
in addition to other covariates, the differences in systolic and
diastolic blood pressures with controls became attenuated to
1.9 (95% CI: −0.3, 4.0) and 1.7 mm Hg (95% CI: 0.1, 3.3),
respectively, for early preterm and 0.5 mm Hg (95% CI:
−1.2, 2.3) and 0.02 mm Hg (95% CI: −1.1, 1.6), respec-
tively, for subjects born late preterm; this adjustment also at-
tenuated the differences in fat mass and body fat percentage
for those who were born early preterm. Further, we reran the
analyses that included birth weight standard deviation score
by using a birth weight standard based on serial ultrasound
measurements of the fetus (20) instead of the commonly
used Finnish standard based on newborn measurements (19).
Again, this did not alter our conclusions.
DISCUSSION
We found that young adults who were born preterm had
higher levels of cardiometabolic risk factors and were 2.5
to 4 times more likely to meet the criteria of metabolic syn-
drome than were their peers who were born at full term. They
also had higher levels of emerging cardiometabolic risk fac-
tors, which suggests that a range of pathophysiological path-
ways might jointly underlie these associations. Although the
results of previous studies have suggested that those born
smallest and most immature have elevated cardiometabolic
risk factors, our study shows that these risk factors and the
full-blown metabolic syndrome are also present in the much
larger group of people who were born less preterm.
Obesity, body composition, and insulin resistance
A key component underlying many characteristics of meta-
bolic syndrome is obesity, particularly abdominal obesity. We
found higher rates of obesity and more central body fat in
adults who were born preterm. This differs from the situation
in adults who were born severely preterm, who tend to be
shorter (26, 27) and have a lower BMI as a result of lower
lean body mass and similar fat percentages (9, 10) compared
with those born at term. Additionally, in a recent meta-analysis
in which they compared 412 adults who born pretermwith 538
controls, Parkinson et al. (9) determined that there were no dif-
ferences in fat percentages; again, this is likely a result of the
cases having been born severely preterm, as the mean gesta-
tional age of those who were born preterm was 30.6 weeks.
Consistent with a previous study in adults with very low
birth weight (10), we found higher fasting and 2-hour insulin
concentrations among the preterm groups, although the differ-
ences in the present study were smaller. A conclusion from
these ﬁndings is that although the large group of adults who
were born less preterm had adverse metabolic characteristics
associated with impaired glucose regulation similar to those
of adults who were born severely preterm, a main contributing
factor to impaired glucose regulation for adults born less pre-
term might be increased body fat with ectopic distribution,
which includes increased hepatic fat accumulation; whereas
for the smallest preterm individuals, a main contributing factor
to impaired glucose regulation may be low muscle mass.
Our subjects were relatively young. As expected, few of
them fulﬁlled the criteria for type 2 diabetes mellitus or im-
paired glucose tolerance. Studies in older adults have suggested
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that higher rates of type 2 diabetes mellitus occur in adults
who were born preterm (27–30); however, such studies are
based on national registers or self-reporting and, thus, involve
a degree of uncertainty. Our study, on the other hand, pre-
sents direct evidence that abnormal metabolic characteristics
are already present in young adult life.
Blood pressure
Our ﬁndings are consistent with a dose-response relation-
ship between a shorter length of gestation and higher blood
pressure, a ﬁnding that has been supported by population-
based studies (14, 31) as well as studies of adults who were
born preterm with a very low birth weight (5, 6, 10, 32). High
blood pressure is strongly associated with cardiovascular
mortality (33, 34) and, globally, is a leading risk factor of
death and disease (35). Small differences can be important;
for example, although we found a difference of 2.5 mm Hg
in diastolic blood pressure between the early preterm group
and controls, a difference of 2 mm Hg is associated with a
15% reduction in the risk of stroke (36).
Lipid profile
Previous ﬁndings that concern the association between
preterm birth and serum lipid levels in adulthood have been
inconsistent (9, 10, 37, 38). We found that women who were
born early preterm had lower levels of HDL-C and its precur-
sor apolipoprotein A1 than did women who were born at
term. The difference of 11.4% that we found in HDL-C level
corresponds to approximately 0.21 mmol/L. A reduction of
0.26 mmol/L has been associated with a 10% increase in the
risk of coronary heart disease (39).
Other biochemical markers of metabolic syndrome
In addition to the established components of metabolic syn-
drome, we found alterations in a wide range of biomarkers that
reﬂect different underlying pathophysiological pathways. These
include uric acid, the concentrations of which were more than
20% higher in both the early and late preterm groups than in
the controls. Levels of liver transaminases were also higher in
adults whowere born preterm, to such an extent that participants
with a moderate or high fatty liver index (a proposed marker of
nonalcoholic fatty liver disease) were almost exclusively born
preterm. We are unaware of any previous reports on uric acid
or liver enzymes in adults who were born preterm. Uric acid
stimulates oxidative stress, endothelial dysfunction, inﬂamma-
tion, and vasoconstriction and is a strong predictor of type 2 di-
abetesmellitus and cardiovascular disease, independent of other
metabolic syndrome components (40). Liver transaminases and
nonalcoholic fatty liver disease also predict these disorders, al-
though the literature is less consistent with regard to the extent
that they are independent indicators of pathology rather than
general markers of metabolic syndrome (41, 42).
Limitations and strengths of the study
The main strength of the present study is the study popula-
tion, which was chosen to include the whole range of preterm
births in a speciﬁc geographic area. Another strength is the
comprehensive measurements of conventional and emerging
cardiometabolic risk factors. As to limitations, participation
bias cannot be excluded, although a detailed nonparticipant
analysis did not raise any concern for such bias. In particular, in
the proportion of participants who had undergone an examina-
tion at 16 years of age, there was no indication that participants
whowere born preterm and who had elevated cardiometabolic
risk factors during the study period would have been over-
represented in the preterm groups. Although we adjusted for
several key confounders, residual confounding remains a pos-
sibility. In addition, collider stratiﬁcation bias is possible after
adjustment for intermediate factors, such as BMI, physical ac-
tivity level, and smoking status, in the regression models; this
is unlikely to have any signiﬁcant effect, as these adjustments
had a negligible effect on the results. There was some differ-
ence in the proportion of the late preterm and control groups
recruited through the NFBC or FMBR; therefore, we adjusted
for the recruitment cohort. We had no data to distinguish be-
tween spontaneous and medically indicated preterm birth. In-
stead, we relied on proxy measures, such as being small for
gestational age or maternal hypertension in pregnancy, that,
nevertheless, are likely to cover amajor proportion of indicated
preterm deliveries. Moreover, although we had sufﬁcient power
for most outcomes, power was limited for more rare out-
comes, such as moderate or high fatty liver index.
Conclusions
We found that young adults who were born preterm had
elevated levels of conventional and emerging cardiometa-
bolic risk factors associated with metabolic syndrome, as
well as a 2.5 to 4 times greater risk of full-blown syndrome
than those born at term. These risks were also present in the
large group of young adults who were born late preterm,
which is consistent with a dose-response relationship be-
tween the degree of prematurity and metabolic syndrome.
Our results call for the targeted promotion of a healthy life-
style and vigilance in the early detection of metabolic syn-
drome in the over 10% of people born preterm.
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